Kite Pharma Microsite

Welcome to the Kite Virtual Experience

Kite is the leader in cell therapy

Mission to reshape
cancer care

RAPID AND RELIABLE
MANUFACTURING^1-3

Transformational
Treatment

Mission to reshape
cancer care

RAPID AND RELIABLE
MANUFACTURING^1-3

Transformational
Treatment

A SINGULAR focus on cell therapy, with 2 CAR T treatments approved
across 4 different hematologic malignancies

A SINGULAR focus on
cell therapy, with 2 CAR T
treatments approved across
4 different hematologic
malignancies

scroll down to learn about the Kite manufacturing process

Kite's state-of-the-art
manufacturing process in action

Take the guided tour

EXPLORE EACH STEP OF THE CAR T CELL JOURNEY IN THIS INTERACTIVE PDF

CAR T CELL JOURNEY PDF

Download Kite Cell Journey Interactive PDF

CAR T CELL JOURNEY PDF

CAR T=chimeric antigen receptor T cell.

References

1. Data on file [1]. Kite Pharma, Inc; 2021. 2. Data on file [2]. Kite Pharma, Inc; 2021. 3. Data on file [3]. Kite Pharma, Inc; 2021.

The content of this site is intended for US residents only. The content on this site may not apply to non-US audiences as regulatory control, legal requirements, and/or medical practices may vary in other countries.

KITE and the Kite Logo are trademarks of Kite Pharma, Inc. GILEAD and the Gilead Logo are trademarks of Gilead Sciences, Inc. All other trademarks referenced herein are the property of their respective owners.

© 2021 Kite Pharma, Inc. All right reserved. |
US-CORP-0005 11/2021